Services

Toxicology

Pharmacology

Animal Model Development

Medical Device Testing

In Vitro Screening

Custom Assay Development

Vivarium Rental

Histology

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Species

Non-human Primates

Dogs

Minipigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Careers

Request a Quote

Logo
☰
  • Services ⌄
    • Toxicology
    • Pharmacology
    • Animal Model Development
    • Medical Device Testing
    • In Vitro Screening
    • Custom Assay Development
    • Vivarium Rental
    • Histology
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Minipigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Careers
    • Request a Quote

BTS Research Successfully Completes USDA Inspection with Zero Findings

  • Post author:PacConAdmin
  • Post published:September 15, 2024
  • Post category:BTS News/News/Uncategorized

BTS Research Successfully Completes USDA Inspection with Zero Findings San Diego, CA - August 28, 2024 - BTS Research, a leading contract research organization specializing in preclinical research services, is…

Continue ReadingBTS Research Successfully Completes USDA Inspection with Zero Findings

PharmaLegacy acquires preclinical CRO BTS Research,

  • Post author:PacConAdmin
  • Post published:August 29, 2024
  • Post category:BTS News/News

PharmaLegacy acquires preclinical CRO BTS Research PharmaLegacy acquires preclinical CRO BTS Research, strengthening its preclinical services and expanding laboratory operations into North America PharmaLegacy Laboratories, a provider of in vitro…

Continue ReadingPharmaLegacy acquires preclinical CRO BTS Research,

BTS Research Addresses FDA Warning Letter Satisfactorily

  • Post author:PacConAdmin
  • Post published:May 1, 2024
  • Post category:BTS News/News

BTS Research Addresses FDA Warning Letter Satisfactorily From the desk of the President & CEO, April 1st, 2024 BTS is very pleased to have received a satisfactory completion of the findings…

Continue ReadingBTS Research Addresses FDA Warning Letter Satisfactorily
Read more about the article BTS Research Completes Corrections of FDA 483 Observations

BTS Research Completes Corrections of FDA 483 Observations

  • Post author:PacConAdmin
  • Post published:February 23, 2024
  • Post category:BTS News/News

BTS Research Completes Corrections of FDA 483 Observations From the desk of the President & CEO On July 8, 2022, U.S. Food and Drug Administration (FDA) Investigator concluded an inspection…

Continue ReadingBTS Research Completes Corrections of FDA 483 Observations

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:
6042 Cornerstone Court W
Suite E
San Diego, CA 92121
Social::
© 2025 BioLegacy Research. All rights reserved.
BioLegacy research is a PharmaLegacy Laboratories company